Leone, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 9801
NA - Nord America 7979
AS - Asia 2285
SA - Sud America 60
AF - Africa 56
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 8
Totale 20227
Nazione #
US - Stati Uniti d'America 7908
DE - Germania 4981
CN - Cina 1808
SE - Svezia 1571
UA - Ucraina 1074
FR - Francia 473
IT - Italia 460
GB - Regno Unito 407
PL - Polonia 329
FI - Finlandia 212
IN - India 182
TR - Turchia 152
BE - Belgio 74
CI - Costa d'Avorio 49
RU - Federazione Russa 47
CA - Canada 41
JP - Giappone 39
AU - Australia 33
NL - Olanda 30
BR - Brasile 28
ES - Italia 27
IR - Iran 24
MX - Messico 22
IE - Irlanda 21
AR - Argentina 19
VN - Vietnam 17
RO - Romania 15
ID - Indonesia 10
HU - Ungheria 9
AT - Austria 8
GR - Grecia 8
CH - Svizzera 7
EU - Europa 7
KR - Corea 7
SG - Singapore 7
CO - Colombia 6
CZ - Repubblica Ceca 6
IL - Israele 6
AE - Emirati Arabi Uniti 5
LU - Lussemburgo 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
BD - Bangladesh 4
BZ - Belize 4
MY - Malesia 4
TH - Thailandia 4
TW - Taiwan 4
BG - Bulgaria 3
BY - Bielorussia 3
CR - Costa Rica 3
LV - Lettonia 3
MK - Macedonia 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DK - Danimarca 2
EG - Egitto 2
HR - Croazia 2
IS - Islanda 2
LB - Libano 2
A1 - ???statistics.table.value.countryCode.A1??? 1
CL - Cile 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
GH - Ghana 1
HK - Hong Kong 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 20227
Città #
Chandler 1607
Jacksonville 699
Nanjing 454
San Mateo 451
Dearborn 448
Ashburn 413
Ann Arbor 352
Nürnberg 335
Warsaw 314
Woodbridge 270
Houston 261
Wilmington 249
Beijing 204
Hangzhou 182
Nanchang 179
Seattle 174
Redwood City 154
Lawrence 148
Izmir 133
Bremen 131
Boston 124
Marseille 120
Munich 116
Fairfield 107
Milan 107
Kunming 101
Lancaster 101
Los Angeles 95
Cattolica 81
Shenyang 79
Zhengzhou 72
Brussels 70
University Park 67
Hebei 63
Tianjin 61
Leawood 59
Princeton 57
Mountain View 55
Guangzhou 50
Abidjan 49
Changsha 48
Hefei 48
Auburn Hills 47
Jiaxing 46
Norwalk 46
Redmond 45
Chicago 44
Boardman 40
Shanghai 40
Cambridge 35
Fremont 34
Jinan 34
Augusta 26
Philadelphia 24
Lanzhou 23
Rome 23
Simi Valley 23
Changchun 21
Detroit 21
Chatsworth 19
San Jose 19
Buffalo 17
San Diego 17
Wayne 17
Costa Mesa 16
Federal 16
Mexico 16
Tobarra 16
Hanoi 14
Ningbo 14
Taizhou 14
Indiana 13
Ypsilanti 13
Falls Church 12
Berlin 11
Dublin 11
Helsinki 11
Kocaeli 11
Kraków 11
New York 11
São Paulo 11
Edinburgh 10
Kish 10
Monmouth Junction 10
Toronto 10
Amsterdam 9
Chengdu 9
London 9
Mumbai 9
Phoenix 9
Sydney 9
Verona 8
San Francisco 7
Alghero 6
Enterprise 6
Gurgaon 6
Napoli 6
Ottawa 6
Tettnang 6
Tokyo 6
Totale 9921
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 807
Incidence of acute myeloid leukemia after breast cancer 323
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 291
Factors associated with mortality in bacteremic patients with haematologic malignancies 286
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 218
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 213
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 212
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 212
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 195
A Novel Route of Transplantation of Human Cord Blood Stem Cells in Preimmune Fetal Sheep: The Intracelomic Cavity 180
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 177
A) A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 166
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 162
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 159
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 154
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 154
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 153
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 152
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 144
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 143
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 141
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 140
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 133
Von hippel-lindau disease and erythrocytosis 133
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 133
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 132
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 130
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 125
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 123
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 123
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 123
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 122
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 122
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 121
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 121
Correlation between paraproteinaemia and viral reactivation after allo-SCT 121
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 121
Why methylation is not a marker predictive of response to hypomethylating agents 121
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 121
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 120
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 120
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 119
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 119
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 117
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 116
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 114
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 114
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 113
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 113
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 113
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 112
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 112
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 112
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 110
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 108
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 108
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 108
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 107
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 106
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 106
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 105
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 105
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 105
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 104
The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. 104
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 104
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 104
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 104
Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype 103
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 102
Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation 102
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 100
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 100
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 99
T lymphocyte subsets and platelet-associated IgG in idiopathic thrombocytopenic purpura: effect of splenectomy. 99
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 97
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 97
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 97
Similarities and differences between therapy-related and elderly acute myeloid leukemia 96
Non-invasive detection of fetal Rhesus D Status: A comparison between Polymerase Chain Reaction and flow Cytometry 96
Primary plasma cell leukemia followed by testicular plasmacytoma 96
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 96
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine 95
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 95
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 95
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 94
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 94
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 94
Epigenetic changes in therapy-related MDS/AML 93
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 93
In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells 93
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 92
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 91
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 91
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 91
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 90
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 90
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma. 90
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 90
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database 90
Totale 13150
Categoria #
all - tutte 36966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018152 0000 00 00 007874
2018/20192628 887690108 480255 414182 136252309238
2019/20204059 659329253297 404491 360154 295267277273
2020/20212596 9427964242 293211 32259 28615552665
2021/20222084 21924037106 13877 53345 85137283364
2022/20234334 520641333725 310530 243349 515541140
Totale 20352